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doi:10.1016/j.jtcvs.2008.02.017Objective: The aim of this study was to compare the outcome of the double-switch
procedure for congenitally corrected transposition of the great arteries for patients
completing morphologic left ventricle training by means of pulmonary artery banding
with the outcome of patients whose morphologic left ventricle did not require training.
Methods: A retrospective study of all patients undergoing the double-switch proce-
dure from 1991 through 2004 was performed. Patients were divided into 2 groups:
those not requiring morphologic left ventricle training (n5 33) and those completing
morphologic left ventricle training by means of pulmonary artery banding (n 5 11).
Results: The time spent with the morphologic left ventricle conditioned at systemic
pressures was longer for the group not requiring morphologic left ventricle training
(median, 730 days; interquartile range, 399–1234 vs median, 436 days; interquartile
range, 411–646; P5 .19). The overall mortality (not requiring morphologic left ven-
tricle training, 12.1%; requiring morphologic left ventricle training, 9.1%; P5 1) and
rate of death/transplantation, development of moderate-to-severe morphologic left
ventricle dysfunction, or both (not requiring morphologic left ventricle training,
21.2%; requiring morphologic left ventricle training, 45.5%; P 5 .14) were similar
between groups. Actuarial freedom from death/transplantation with good morpho-
logic left ventricular function was superior for patients whose morphologic left ven-
tricle did not require training (P 5 .04). The follow-up was not different between
groups (not requiring training: median, 1435 days [interquartile range, 285–2570
days]; requiring morphologic left ventricle training: median, 568 days [interquartile
range, 399–1465 days]; P 5 .14). On multivariate analysis, the completion of mor-
phologic left ventricle training predicted death/transplantation, development of mod-
erate-to-severe morphologic left ventricle dysfunction, or both (P 5 .02).
Conclusions: The early results of the double-switch procedure in patients whose mor-
phologic left ventricle required training compare favorably with those of patients
whose morphologic left ventricle required no training. There is an increased risk of
deterioration of morphologic left ventricle function over time in patients whose
morphologic left ventricle requires training, and these patients need to be followed
up regularly to detect this.
C
ongenitally corrected transposition of the great arteries (CCTGA) is character-
ized by atrioventricular and ventriculoarterial discordance. The morphologic
left ventricle (mLV) and morphologic right ventricle (mRV) support the
pulmonary and systemic circulations, respectively. CCTGA can be associated withThe Journal of Thoracic and Cardiovascular Surgery c Volume 135, Number 5 1137
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DAbbreviations and Acronyms
AR 5 aortic regurgitation
CCF 5 congestive cardiac failure
CCTGA 5 congenitally corrected transposition
of the great arteries
CPB 5 cardiopulmonary bypass
DS 5 double-switch
IQR 5 interquartile range
ITU 5 intensive therapy unit
mLV 5 morphologic left ventricle
mLVOTO 5 morphologic left ventricular outflow
tract obstruction
mRV 5 morphologic right ventricle
neoAR 5 new aortic valve
PA 5 pulmonary artery
PHT 5 pulmonary hypertension
TR 5 tricuspid regurgitation
VSD 5 ventricular septal defect
95% CL 5 95% confidence limits
ventricular septal defects (VSDs), morphologic left ventricu-
lar outflow tract obstruction (mLVOTO), and tricuspid valve
dysplasia.1,2
Conventional management can require repair of these
associated intracardiac lesions. This leaves the mRV in the sys-
temic circulation, a task for which its anatomy and coronary
blood supply might be unsuited,3,4 and is associated with pro-
gressive mRV dysfunction and tricuspid regurgitation (TR)5-8
and a reported survival at 1 year of 84%, decreasing to 60% at
15 years.9
This poor outcome has increased interest in operations
that restore the mRV and mLV to their respective pulmonary
and systemic circulations. This is achieved by combining an
atrial with an arterial switch, the double-switch (DS) pro-
cedure.10 Although no randomized prospective trial has
compared conventional repair with the DS procedure, clinical
series suggest that the DS procedure is associated with a low
operative mortality, superior survival, and New York Heart
Association functional class.10-12
A successful DS procedure depends on the mLV’s ability
to support the systemic circulation. If the mLV has been
exposed to systemic pressures from birth, either by virtue
of an unrestrictive VSD, congestive cardiac failure (CCF)
with associated pulmonary hypertension (PHT), or both, it
remains conditioned and capable of sustaining systemic
pressures after the DS procedure. In the absence of these
abnormalities or after conventional repair, the mLV performs
within the lower-resistance pulmonary circulation, and its
contractile mass involutes. In these circumstances the mLV
will fail after restoration to the systemic circulation.
The mLV can be trained to support the systemic circulation
by applying a pulmonary artery (PA) band to increase its after-
load, expose it to (near-) systemic pressures, and stimulate1138 The Journal of Thoracic and Cardiovascular Surgery c MmLV hypertrophy.13 Concerns exist that patients undergoing
the DS procedure after mLV training by means of PA banding
might have earlier mLV dysfunction than those not requiring
training.11,13,14 The aim of this study was to compare the
results between patients whose mLV required training by
means of PA banding and those whose mLV required no
training.
Materials and Methods
A retrospective review of the notes was conducted on all patients
undergoing the DS procedure at a single center from November
1991 through August 2004. Patients were divided into 2 groups
according to the requirement for mLV training (Figure E1). Patients
whose mLV required no training (n5 33) were those who had main-
tained systemic mLV pressures from birth. These patients had an
unrestrictive VSD but required protective PA banding to reduce
excessive pulmonary blood flow (n 5 19), had unrestrictive VSD
but with mLVOTO that provided inherent protection from excessive
pulmonary blood flow (n5 3), or had established CCF/PHT (n5 11).
The latter group included 2 patients who had CCF/PHT after conven-
tional repair before referral to our institution. Patients in the trained
mLV group (n 5 11) had a restrictive VSD or intact septum and
had successfully completed mLV training by means of PA banding.
Data Collection
Demographic, diagnostic, operative, investigative, and follow-up
details were recorded. The mLV conditioning time was the time
the ventricle was subjected to systemic pressures before the DS pro-
cedure. For the group not requiring training, this was from the date
of birth to the DS procedure, and for the group requiring training,
this was from the date of first banding to the DS procedure.
The method of assessing ventricular and valvular function was
echocardiography. Results were obtained from the reports submitted
by the referring center or from echocardiograms obtained by our
own department. An independent blinded cardiologist (CM)
reviewed all available echocardiograms to avoid interobserver error
and bias from knowledge of the clinical situation. Severity of valvu-
lar regurgitation was graded as none, mild, moderate, or severe.
Ventricular function was scored as good function or moderate or
severe dysfunction. The posterior wall thickness (in millimeters)
of the mLV was measured by using the electronic caliper technique.
Inotrope use and left atrial measurements after the DS procedure
were recorded at arrival in the intensive therapy unit (ITU) and
48 hours later. Inotrope scores were calculated as follows:
Dobutamine dose ðmg=kg=minÞ1ð303Milrinonedose ½mg=kg=
min Þ1ð1003Adrenaline dose ½mg=kg=min Þ .15 Early mortality
was defined as death 30 days or sooner after surgical intervention
or before hospital discharge. The New York Heart Association func-
tional scale was used to determine the symptomatic status of patients.
Duration of follow-up was defined as days from the DS procedure
until the last documented clinical assessment.
Data Analysis
Data were analyzed by using SPSS software (version 12; SPSS, Inc,
Chicago, Ill). Categorical or ordinal data are expressed as a percent-
age that accounts for missing data, and comparisons were made by
using the c2, Fisher exact, or Kendall t b tests, respectively.ay 2008
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DContinuous data are presented as means (95% confidence limits
[95% CL]) or medians (25%–75% interquartile ranges [IQRs]). Nor-
mally distributed data were compared by using independent t tests.
Skewed data were logarithmically transformed or analyzed nonpara-
metrically. Actuarial freedom from event after the DS procedure
was estimated by using the Kaplan–Meier method, and groups were
compared by using the Breslow test. Events were defined as death/
transplantation, the development of moderate-to-severe mLV
dysfunction, or both. The time to development of mLV dysfunction
depended on the frequency of assessment. To account for this, the
time to event was analyzed by using 3 alternatives: the time from
the DS procedure to the last report identifying good mLV function
(date of the DS procedure if moderate-to-severe mLV dysfunction
persisted); the time from the DS procedure to the first report identi-
fying moderate-to-severe mLV dysfunction; and finally, the mean
delay between these 2. All event curves were similarly significant
(P 5 .03, .04, and .04), and the first report identifying moderate-
to-severe mLV dysfunction was used. The multivariate analysis
was performed by using Cox regression.
PA Banding Technique for mLV Training
The technique for PA banding for mLV training has been des-
cribed previously.12,16 The band was applied to increase the mLV
pressure to 66% to 80% of systemic value while maintaining ade-
quate mLV systolic function. The mLV pressure was monitored
during and for 12 to 24 hours after the operation by using an in-
dwelling mLV line and was supported by intravenous dobutamine
infusion (#10 mg $ kg21 $ min21). Early rebanding was considered
if the mLV/mRV ratio was less than 0.6. Subsequent assessment for
suitability for the DS procedure was by means of transthoracic
echocardiography and cardiac catheterization. Progression to the
DS procedure was considered when the patient had recovered
from surgical intervention and, where possible, had been discharged
home and then reviewed by the cardiologist, with cardiac catheter-
ization demonstrating that mLV pressure was at (near-) systemic
pressure with moderate-to-good systolic mLV function.
DS Technique
The technique for the DS procedure has been described previ-
ously.12,17 Cardiopulmonary bypass (CPB) was instituted by means
of caval cannulation with ascending aortic return, myocardial protec-
tion was afforded by intermittent cold crystalloid cardioplegia during
aortic crossclamping, and the operation was performed with periods
of deep hypothermic circulatory arrest. After CPB, echocardio-
graphic assessment was used to gauge the adequacy of the repair.
The sternum was closed primarily or temporarily left open with
a fenestrated protective polytetrafluoroethylene patch* sutured to
the skin to accommodate the size of the heart in anticipation of
myocardial dysfunction.
Results
Total Patient Population
Forty-four patients underwent the DS procedure during
the study period. Their median age was 887.5 days (IQR,
* Gore-Tex patch, registered trademark of W. L. Gore & Associates, Inc, Newark,
Del.The Journal of Thora559–2030 days), mean weight was 14.7 kg (IQR, 12–17.3 kg),
and male/female ratio was 3.9:1. The early mortality was 2
(4.5%) of 44, the overall mortality was 5 (11.4%) of 44, and
the death/transplantation rate was 7(15.9%) of 44. Median
follow-up was 1269 days (IQR, 175.2–2510.8 days). The
actuarial freedom from death/transplantation, moderate-
to-severe mLV dysfunction, or both was 84.6% at 1 year,
80.4% at 5 years, and 72.3% at 10 years.
Demographic, Referral, and Anatomic
Characteristics
More information on demographic, referral, and anatomic
characteristics is available in Table 1. Age and weight at
the time of the DS procedure were greater for the group
requiring mLV training. The incidence of anatomic charac-
teristics was similar. There were no significant differences
in the timing of diagnosis. The pattern of referral demon-
strated that more patients in the group requiring mLV training
had been referred internationally and fewer had been referred
nationally compared with those not requiring training.
Pre-DS Procedure Variables
More information on pre-DS procedure variables is available
in Table 1. The mLV/mRV pressure ratios at cardiac catheter-
ization before the DS procedure were similar in both groups.
The conditioning time was longer for those patients not
requiring mLV training, although it did not reach statistical
significance. In the group requiring training, posterior wall
thickness data were available in 9 patients before PA banding
and in 10 patients before the DS procedure. PA banding for
mLV training significantly increased the posterior wall thick-
ness (pre-PA banding mean, 6.2 mm [95% CL, 4.8–7.6 mm];
pre-DS procedure mean, 8 mm [95% CL, 6.6–9.3 mm]; P5
.05). Six patients received PA banding for mLV training but
did not undergo the DS procedure in this hospital. One male
patient from the international catchment area was lost to fol-
low-up, 2 female patients and 1 male patient PA banded as
young adults (ages 15, 20, and 28 years) failed the training
program but are alive and well, 1 male patient PA banded
at age 12 months and progressing well died from diarrhea-
related electrolyte disturbance, and 1 female patient died after
a premature DS procedure conducted at another hospital after
PA banding at age 5 years.
Operative Characteristics at the Time of the DS
Procedure
More information on operative characteristics at the time of
the DS procedure is available in Table 1. There was no differ-
ence in the CPB, aortic crossclamping, and deep hypothermic
circulatory arrest times in the use of the Jatene repair, the
Lecompte maneuver, primary or delayed sternal closure,
the incidence of reopening, and the delay to final sternal
closure in days between groups.cic and Cardiovascular Surgery c Volume 135, Number 5 1139
Surgery for Congenital Heart Disease Quinn et al
CH
DTABLE 1. A comparison of the preoperative, operative, and postoperative results of the double-switch procedure between
patients completing and those not requiring mLV training
mLV without training (n 5 33) Trained mLV (n 5 11)k P value
Preoperative variables
Age (d),k median (IQR) 730 (399–1234) 1882 (1401.5–2346.5) ,.01
Weight (kg),k mean (95% CL)* 12.9 (9.9–16) 19.9 (15.2–24.5) ,.01
Male/female ratiok 3/1 10/1 .41
Antenatal diagnosis 1 (3) 2 (18.2) .15
Referral catchment .05
Local area 6 (18.2) 3 (27.3)
National 17 (51.5) 1 (9.1)
International 10 (30.3) 7 (63.6)
Situs, n (%) .25
Solitus 33 (100) 10 (90.9)
Inversus 0 (0) 1 (9.1)
Cardiac apex, n (%) 1
Dextrocardia 2 (6.1) 1 (9.1)
Mesocardia 1 (3) 0 (0)
Levocardia 30 (90.9) 10 (90.9)
Atrial septum, n (%) .85
Intact 25 (75.8) 9 (81.8)
ASD 3 (9.1) 0 (0)
PFO 5 (15.1) 2 (18.2)
Mitral valve, n (%) 1
Normal 32 (97) 11 (100)
Dysplasia 1 (3) 0 (0)
Tricuspid valve, n (%) 1
Normal 19 (57.6) 7 (63.6)
Dysplasia/Ebstein's anomaly 14 (42.4) 4 (36.4)
Ventricular septum, n (%) ,.01
Intact 7 (21.2) 8 (72.7)
Perimembranous 17 (51.5) 3 (27.3)
Muscular (might be multiple) 9 (27.3) 0 (0)
Aortic valve cusps, n (%) .60
Bicuspid 3 (9.1) 0 (0)
Tricuspid 30 (90.9) 11 (100)
Pulmonary valve, n (%) 1
Bicuspid 3 (9.1) 1 (9.1)
Tricuspid 28 (84.8) 10 (90.9)
Quadricuspid 2 (6.1) 0 (0)
Coarctation 8 (24.2) 1 (9.1) .41
CHB (by time of DS procedure)k 6 (18.2) 2 (18.2) 1
mLV/mRV pressure ratio before DS procedure 0.97 (0.92–1.01) 0.98 (0.82–1.1) .85
mLV function before DS procedure,k n (%) 1
Good function 26 (83.9) 10 (90.9)
Moderate-to-severe function 5 (16.1) 1 (9.1)
mRV function before DS procedure,k n (%) .5
Good function 29 (96.7) 10 (90.9)
Moderate-to-severe dysfunction 1 (3.3) 1 (9.1)
mLV conditioning time (d),k median 730 (399–1234) 436 (411–646) .19
Operative variables
Inotropes/ventilation before DS procedure, n (%) 4 (12.1) 0 (0) .56
CPB time (min),* mean 185 (151–218) 175 (147–202) .67
AXC time (min),* mean 137 (127–147) 128 (116–139) .29
DHCA time (min),* mean 33 (25–41) 22 (9–36) .38
Delayed sternal closure, n (%) 19 (57.6) 6 (54.5) 11140 The Journal of Thoracic and Cardiovascular Surgery c May 2008
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DTABLE 1. Continued
mLV without training (n 5 33) Trained mLV (n 5 11)k P value
Postoperative results
Reopening required, n (%) 7 (21.2) 2 (18.2) 1
Delay to final sternal closure (d) 1.03 (0.6–1.5) 0.64 (0.18–1.0) .18
Delay to final drain removal (d)* 6.75 (3.35–10.15) 5.95 (0.66–11.16) .83
Inotrope score*
ITU arrival 26.2 (18.8–33.6) 26.2 (19.9–32.5) .47
ITU arrival 1 48 h 15 (8.2–21.8) 10.6 (7.2–14.1) .84
LA pressure (mm Hg)
ITU arrival 8.4 (7.3–9.4) 7.7 (6.7–8.7) .33
ITU arrival 1 48 h 8.6 (7.4–9.9) 10.5 (8.1–12.9) .14
Delay to extubation (h)* 127.3 (65.7–188.8) 43.6 (29.6–57.3) .19
Delay to ITU discharge (d)* 9.4 (3.6–15.2) 2.9 (2.3–3.5) .07
Postoperative length of stay (d)* 26.9 (13.4–38.8) 16.2 (8.6–23.7) .43
Peritoneal dialysis, n (%) 3 (9.6) 0 (0) .56
New CHB requiring PPM, n (%) 7 (21.2) 0 (0) .17
mLV function at discharge, n (%) .7
Good function 23 (74.2) 7 (63.6)
Moderate-to-severe function 8 (25.8) 4 (36.4)
NYHA, n (%) 1
I/II 23 (79.3) 9 (81.8)
III/IV 6 (20.7) 2 (22.2)
ACEI, n (%) 1
Not required 10 (41.7) 3 (33.3)
Required 14 (58.3) 5 (66.7)
Diuretics, n (%) .06
Not required 12 (50) 1 (11.1)
Required 12 (50) 8 (88.9)
Moderate-to-severe mLV dysfunction last follow-up, n (%)
All patients 6 (19.4) 6 (54.5) .05
Good mLV before DS procedurey 5 (20) 6 (60) .04
Early mortality, n (%) 2 (6.1) 0 (0) 1
Overall mortality, n (%) 4 (12.1) 1 (9.1) 1
Death/transplantation, n (%) 5 (15.1) 2 (18.2) 1
Death/transplantation 6 moderate-to-severe mLV
dysfunction last follow-up, n (%)
7 (21.2) 5 (45.5) .14
Delay to death/transplantation 6 moderate-to-severe
mLV dysfunction (d), median
1435 (212–2573) 568 (113–1351) .10
Follow-up (d), median 1435 (285–2570) 568 (113–1465) .14
For the definition of morphologic left ventricle conditioning time, see the text. Medians are presented with the 25% to 75% interquartile limits and compared by
means of theMann–Whitney U test. Means are presentedwith the 95% confidence limits and compared by using the independent-variables t test. Proportions
are compared by using the c2 or Fisher exact tests if the numbers in the cell were 5 or less. mLV, Morphologic left ventricle; ASD, atrial septal defect;
PFO, patent foramen ovale; CHB, complete heart block; DS, double-switch;mRV, morphologic right ventricle; CPB, cardiopulmonary bypass; AXC, aortic cross-
clamp; DHCA, deep hypothermic circulatory arrest; ITU, intensive therapy unit; PPM, permanent pacemaker; NYHA, New York Heart Association (dyspnea
scale); ACEI, angiotensin-converting enzyme inhibitor. *Data were log transformed to account for skewed division. yDenominator is based on the associated
subgroup and not the whole group. kFactor used in multivariate analysis.Early Outcomes
More information on early outcomes is available in Table 1.
In the mLV not requiring training group, there were 2 (4.5%)
early deaths, a 2.5-year-old girl with a VSD, mLVOTO, and
good mLV function who died during the operation from low
cardiac output state and a 26-year-old man who underwent
coarctation repair as an infant and subsequently presented
with CCF/PHT and who died on postoperative day 3 from
low cardiac output state.The Journal of ThorInotrope scores and left atrial pressures were similar
between groups at ITU arrival and at 48 hours. In the group
not requiring mLV training, 1 (3%) of 33 patients required
extracorporeal membrane oxygenation, and 7 (21.2%) of
33 patients with complete heart block required permanent
pacing. Only 1 of these had mLVOTO requiring subvalvular
resection during the DS procedure. Although the delay to
extubation and to ITU discharge was almost 3-fold longer
for the group not requiring training, this did not reachacic and Cardiovascular Surgery c Volume 135, Number 5 1141
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Dstatistical significance. The postoperative hospital stay was 10
days longer for the group not requiring training.
Late Outcomes
Information on late outcomes is available in Table 1. Of the
42 patients surviving to discharge, follow-up was longer for
the group not requiring training, although this did not reach
statistical significance. The group not requiring training
experienced 2 further deaths and 1 cardiac transplantation
after the DS procedure. One underwent aortic valve replace-
ment for aortic regurgitation (AR). In the group requiring
training, there was 1 sudden death and 1 cardiac transplanta-
tion. An additional aortic valve replacement for severe AR
was performed in this group.
The overall incidence of death/transplantation, develop-
ment of moderate-to-severe mLV dysfunction, or both was
no different between groups (Table 1). Actuarial freedom
from death/transplantation was similar between groups
(P 5 .65; Figure 1, A), but freedom from death/transplanta-
tion, moderate-to-severe mLV dysfunction, or both was
superior for patients who required no training (P 5 .04;
Figure 1,B). The difference between Figure 1,A, and Figure 1,
B, reflects the prevalence of patients alive but experiencing
moderate-to-severe mLV dysfunction (Figure 1, C). It dem-
onstrates that patients completing mLV training had an
increased prevalence of survivors with mLV dysfunction
throughout the follow-up period, although this difference
began to decrease with time as the prevalence of patients com-
pleting mLV training and surviving with moderate-to-severe
dysfunction decreased. At 1 year after surgical intervention,
39% of patients who completed mLV training were alive
with moderate-to-severe mLV dysfunction compared with
6.3% of patients whose mLV required no training. Moder-
ate-to-severe mLV dysfunction before the DS procedure
(mLV not requiring training, n5 7; mLV receiving training,
n5 1) did not influence the development of mLV dysfunction
after surgical intervention. One patient died 3 days after the
DS procedure, whereas the remaining 7 patients demonstrated
an improvement in mLV function. One of these patients
subsequently had mLV dysfunction and died at 5 months.
Actuarial freedom from death/transplantation, development
of moderate-to-severe mLV dysfunction, or both was similar
for patients with good preoperative mLV function and
patients with moderate-to-severe mLV dysfunction before
surgical intervention (P 5 .310).
Multivariate analysis of preoperative variables (Table 1)
demonstrated that moderate-to-severe mRV dysfunction
before the DS procedure (P 5 .01; hazard ratio, 9.8; 95%
confidence limits, 1.7–54) and the successful completion of
mLV training before the DS procedure (P5 .02; hazard ratio,
0.19; 95% confidence limits, 0.05–0.76) were independent
predictors of death/transplantation, the development of
mLV dysfunction, or both before the DS procedure.1142 The Journal of Thoracic and Cardiovascular Surgery c MFigure 1. A comparison of freedom from death/transplantation
after the double-switch procedure (A); death/transplantation,
moderate-to-severe morphologic left ventricle (mLV) dysfunction,
or both after the double-switch procedure (B); and the actuarial
prevalence of patients free from death/transplantation but with
moderate-to-severe mLV dysfunction (C).ay 2008
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DAtrioventricular and Semilunar Valve Function
More information on atrioventricular and semilunar valve
function is available in Figure E2. There was no difference
between groups in the incidence of moderate-to-severe TR
at diagnosis (ie, before PA banding) or before DS. There
was no difference (P5 .11) between the incidence of moder-
ate-to-severe TR in the group requiring mLV training (8/11
[72.2%] before PA banding) and in those not requiring
training (15/33 [45%]) before the DS procedure. At discharge
after the DS procedure, the incidence of moderate-to-severe
TR decreased in the group not requiring training but remained
increased in the trained mLV group. At last follow-up, the
incidence of moderate-to-severe TR had decreased in both
groups to statistically comparable values. There was no sig-
nificant difference in the incidence of mitral regurgitation be-
tween groups at diagnosis before or after the DS procedure.
The incidence of AR was similar between groups at diagnosis
and before the DS procedure, but after the DS procedure,
regurgitation through the new aortic valve (neoAR) increased
comparably in both groups at discharge and last follow-up.
Discussion
This is one of the largest cohorts of the DS procedure
reported. The demographics, preoperative variables, and
postoperative results are similar to those of previous stud-
ies.11,14,18 The data demonstrate that patients who complete
mLV training by means of PA banding have comparable
early postoperative recoveries with those not requiring train-
ing but were more likely to have deterioration to moderate-to-
severe mLV dysfunction at an earlier stage compared with
patients who did not require training.
The restoration of the mLV to the systemic circulation by
the DS procedure might reduce the incidence of systemic
ventricular failure and midterm mortality associated with con-
ventional repair. The reduction in TR after the DS procedure
might reflect this.19,20 However, patients with CCTGA are
heterogeneous for cardiac morphology and presentation.
The similarities in early outcome between the groups occurred
despite differences in age, weight, and clinical condition. This
suggests that training, selection, and technique produced
equivalent pre-DS and early postoperative mLV function.
Patients with involution of the mLV need to be identified
and considered for training by means of PA banding. This
stimulates an increase in mLV mass as early as 4 days and
is associated with improvements in absolute contractility
and ejection fraction.21,22 It has become an established
method of preparatory training for the arterial switch proce-
dure in patients with the related condition of d-transposition
of the great arteries and for the DS procedure in patients
with CCTGA. Assessment of training was by means of echo-
cardiographic and cardiac catheterization data in this study.
Other techniques, such as magnetic resonance imaging, might
provide additional information.23The Journal of ThorThe durability of mLV function after training by means of
PA banding has been questioned by these and previous data
that highlight a low but appreciable incidence of the trained
mLV failure after the DS procedure. The reasons might in-
clude the development of a neoAR after the DS procedure
or a detrimental effect of training by means of PA banding
on mLV function. NeoAR is a recognized complication after
the DS procedure and can be more frequent in patients whose
PAs have been distorted by means of PA banding. The small
number of patients in this series was unable to detect differ-
ences in neoAR, and its influence on mLV function remains
unclear.
Animal experiments suggest that technique, timing, and
duration of training by means of PA banding might adversely
affect long-term mLV function. In this trial the technique of
PA banding used was an independent predictor of mLV dys-
function. It might cause subendocardial edema, myocardial
necrosis, and fibrosis24 and reduced ventricular work index.25
Experimentally, initial relatively tight sustained banding,
akin to the clinical technique described in this study, might
produce fibrosis and limit increases in ventricular pressure
more than a regimen of twice daily intermittent band tighten-
ing.26 The use of a looser banding circumference with an ini-
tially lower mLV/mRV (0.5–0.67) pressure ratio increasingly
gradually with relative PA growth11 or the use of adjustable
banding (without reoperation) to tailor the PA circumference
to its training requirements27 are clinical alternatives to our
technique. However, less-aggressive banding techniques
have also been associated with decreases in mLV function
after the DS procedure,18 and the contribution of these
techniques to mLV has not been directly compared in clinical
trials. The adjustable banding technique is an attractive
proposition but yet to be fully evaluated.
Age of banding might determine the later function of the
myocardium. The hypertrophic response to afterload training
is accompanied by hyperplasia in younger, less mature
hearts. This is less prevalent in more mature hearts.28
When considering mLV training, hypertrophy is an adaptive
phenomenon with beneficial short-term but possibly adverse
long-term consequences. Adult patients with mLV hypertro-
phy caused by hypertension or aortic stenosis are at risk of
adverse cardiovascular events.29 The quality of hypertrophy
might account for the less effective durability of mLV train-
ing in older patients.
Study Limitations
The study is limited by its retrospective design, which
might include bias to the degree of mLV dysfunction. The
data from echocardiographic results were dichotomized
into normal-to-mild and moderate-to-severe, which limits
the degree of error in assessment and, at the time of blinded
review, was not influenced by knowledge of the patient’s
clinical condition. The 13-year period of surgical experience
might have been associated with changes in selection andacic and Cardiovascular Surgery c Volume 135, Number 5 1143
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Dmanagement of patients undergoing the DS procedure that
could influence early and midterm results.
Conclusion
Our technique for mLV training by means of PA banding
adequately prepares the mLV for the DS procedure and
allows early post-DS results to compare favorably with those
of patients whose mLV requires no training. In the interme-
diate term there is an increased risk of deterioration of mLV
function over time, and these patients need to be followed up
regularly in order to detect this.
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Figure E1. The characterization of patient groups undergoing the
DS procedure. The bold-bordered boxes represent the final group-
ing of patients (untrained mLV group CCF and PHT, n 5 11; VSD
with proactive PA banding mLVOTO, n 5 22; trained mLV group
by means of PA banding for mLV training, n5 11). CCTGA, Congen-
itally corrected transposition of the great arteries; CCF, congestive
cardiac failure; PHT, pulmonary hypertension; VSD, ventricular
septal defect; PA, pulmonary artery; mLVOTO, morphologic left
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Figure E2. A comparison of moderate-to-severe valvular regurgi-
tation between groups: A, tricuspid valve (Factor used in multivar-
iate analysis); B, mitral valve; C, aortic valve. mLV, Morphologic
left ventricle; TR, tricuspid regurgitation; DS, double-stitch proce-
dure; d/c, discharge; f/u, follow-up; CCTGA, congenitally corrected
transposition of the great arteries; MR, mitral regurgitation; AR,
aortic regurgitation. Numbers on graph represent missing values.1144.e2 The Journal of Thoracic and Cardiovascular Surgery c May 2008
